Pat | Sex | Age | EPO, mU/ml | EPO level | Hb, g/dl | Hb level | VHL mutation | Cyst | Size, cm3 |
---|---|---|---|---|---|---|---|---|---|
1 | f | 57 | 24 | n | 12.9 | n | + | + | 0.1 |
2 | f | 60 | 3 | ↓ | 14 | n | + | – | 8.1 |
3 | f | 42 | 41 | ↑ | 11.9 | ↓ | 746 T/A | – | 0.9 |
4 | f | 39 | 34.2 | ↑ | 14.7 | n | + | – | 2.2 |
5 | f | 48 | 13.2 | n | 13.7 | n | del 2b | + | 0.3 |
6 | f | 55 | 7.6 | n | 16.6 | ↑ | 407 C/T | + | 9.6 |
7 | f | 37 | 15.5 | n | 12.2 | n | + | + | 0.1 |
8 | f | 57 | 14.9 | n | 14.8 | n | 505 T/C | + | 0.1 |
9 | f | 20 | 11.5 | n | 14.2 | n | + | + | 0.1 |
10 | f | 55 | 7.3 | n | 14.1 | n | + | + | 0.1 |
11 | f | 42 | 22 | n | 11 | ↓ | no | + | 0.4 |
12 | f | 35 | 20.5 | n | 14 | n | + | + | 1.4 |
13 | f | 44 | 13.2 | n | 13.3 | n | + | – | 0.8 |
14 | f | 53 | 7.9 | n | 15.8 | ↑ | + | – | 5.1 |
15 | f | 75 | 36.3 | ↑ | 17.1 | ↑ | 505 T/C | + | 13.6 |
16 | f | 56 | 12.9 | n | 13.7 | n | 505 T/C | – | 0.4 |
17 | m | 47 | 17.5 | n | 18.3 | ↑ | 694 C/T | – | 5.3 |
18 | m | 39 | 5.6 | n | 16.1 | n | 407 C/G | + | 0.2 |
19 | m | 39 | 8.8 | n | 15.7 | n | del ex 2 | + | 0.1 |
20 | m | 39 | 10.2 | n | 14.9 | n | del ex 3 | – | 0.1 |
21 | m | 52 | 9.6 | n | 15.5 | n | no | + | 0.1 |
22 | m | 28 | 11 | n | 13.6 | n | 430 C/T | + | 0.1 |
23 | m | 27 | 11.5 | n | 14 | n | del 5 kb | + | 0.4 |
24 | m | 44 | 106 | ↑ | 15.1 | n | del ex1–3 IRAK2 | + | 0.1 |
25 | m | 52 | 14.5 | n | 14.6 | n | 738 C/A | – | 1.6 |
26 | m | 41 | 7.6 | n | 19.4 | ↑ | 553 G/A | – | 6.7 |
27 | m | 25 | 15.1 | n | 16.3 | n | + | + | 0.1 |
28 | m | 31 | 10.6 | n | 16 | n | del 2 kb | – | 0.1 |
29 | m | 39 | 7.3 | n | 16.6 | n | 676 + 2 T/C | + | 1.3 |
30 | m | 48 | 21.6 | n | 14.8 | n | 677-1G/C | – | 0.2 |
31 | m | 32 | 87.6 | ↑ | 15.1 | n | 454 C/T | – | 0.2 |